Literature DB >> 22695732

Powder strength distributions for understanding de-agglomeration of lactose powders.

Shyamal C Das1, Srinivas Ravindra Babu Behara, Jurgen B Bulitta, David A V Morton, Ian Larson, Peter J Stewart.   

Abstract

PURPOSE: The purpose was to calculate distributions of powder strength of a cohesive bed to explain the de-agglomeration of lactose.
METHODS: De-agglomeration profiles of Lactohale 300(®) (L300) and micronized lactose (ML) were constructed by particle sizing aerosolised plumes dispersed at air flow rates of 30-180 l/min. The work of cohesion distribution was determined by inverse gas chromatography. The primary particle size and tapped density distributions were determined. Powder strength distributions were calculated by Monte Carlo simulations from distributions of particle size, work of cohesion and tapped density measurements.
RESULTS: The powder strength distribution of L300 was broader than that of ML. Up to 85th percentile, powder strength of L300 was lower than ML which was consistent with the better de-agglomeration of L300 at low flow rates. However, ~15% of L300 particles had higher powder strength than ML which likely to cause lower de-agglomeration for L300 at high air flow rates.
CONCLUSION: Cohesive lactose powders formed matrices of non-homogenous powder strength. De-agglomeration of cohesive powders has been shown to be related to powder strength. This study provided new insights into powder de-agglomeration by a new approach for calculating powder strength distributions to better understand complex de-agglomeration behaviour.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22695732     DOI: 10.1007/s11095-012-0799-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation.

Authors:  Handoko Adi; Ian Larson; Herbert Chiou; Paul Young; Daniela Traini; Peter Stewart
Journal:  Pharm Res       Date:  2006-09-14       Impact factor: 4.200

Review 2.  The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations.

Authors:  Matthew D Jones; Robert Price
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

3.  Evaluation of a breath actuated pressurized aerosol.

Authors:  T J Coady; H J Davies; P Barnes
Journal:  Clin Allergy       Date:  1976-01

4.  Inverse gas chromatographic method for measuring the dispersive surface energy distribution for particulates.

Authors:  Pirre P Ylä-Mäihäniemi; Jerry Y Y Heng; Frank Thielmann; Daryl R Williams
Journal:  Langmuir       Date:  2008-08-05       Impact factor: 3.882

5.  Structural influence of cohesive mixtures of salbutamol sulphate and lactose on aerosolisation and de-agglomeration behaviour under dynamic conditions.

Authors:  Srinivas Ravindra Babu Behara; Paul Kippax; Michelle P McIntosh; David A V Morton; Ian Larson; Peter Stewart
Journal:  Eur J Pharm Sci       Date:  2010-11-26       Impact factor: 4.384

6.  Determination of surface heterogeneity of D-mannitol by sessile drop contact angle and finite concentration inverse gas chromatography.

Authors:  Raimundo Ho; Steven J Hinder; John F Watts; Sarah E Dilworth; Daryl R Williams; Jerry Y Y Heng
Journal:  Int J Pharm       Date:  2009-12-16       Impact factor: 5.875

7.  Influence of storage relative humidity on the dispersion of salmeterol xinafoate powders for inhalation.

Authors:  Shyamal Das; Ian Larson; Paul Young; Peter Stewart
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

8.  Inspiratory flow rate and dynamic lung function in cystic fibrosis and chronic obstructive lung diseases.

Authors:  P S Sarinas; T E Robinson; A R Clark; J Canfield; R K Chitkara; R B Fick
Journal:  Chest       Date:  1998-10       Impact factor: 9.410

9.  Magnesium stearate increases salbutamol sulphate dispersion: what is the mechanism?

Authors:  Tracy Tay; Shyamal Das; Peter Stewart
Journal:  Int J Pharm       Date:  2009-09-11       Impact factor: 5.875

10.  Insight into pressure drop dependent efficiencies of dry powder inhalers.

Authors:  Srinivas Ravindra Babu Behara; Ian Larson; Paul Kippax; Peter Stewart; David A V Morton
Journal:  Eur J Pharm Sci       Date:  2012-06-14       Impact factor: 4.384

View more
  3 in total

Review 1.  In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches.

Authors:  Ben Forbes; Per Bäckman; David Christopher; Myrna Dolovich; Bing V Li; Beth Morgan
Journal:  AAPS J       Date:  2015-05-05       Impact factor: 4.009

2.  Rapid characterisation of the inherent dispersibility of respirable powders using dry dispersion laser diffraction.

Authors:  Sara Jaffari; Ben Forbes; Elizabeth Collins; David J Barlow; Gary P Martin; Darragh Murnane
Journal:  Int J Pharm       Date:  2013-02-19       Impact factor: 5.875

3.  Evidence for the existence of powder sub-populations in micronized materials: aerodynamic size-fractions of aerosolized powders possess distinct physicochemical properties.

Authors:  Sara Jaffari; Ben Forbes; Elizabeth Collins; Jiyi Khoo; Gary P Martin; Darragh Murnane
Journal:  Pharm Res       Date:  2014-12       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.